Abstract
Treatment of Staphylococcus aureus biofilm infections using conventional antibiotic therapy is challenging as only doses that are sublethal to the biofilm can be administered safely to patients. A potential solution to this challenge is targeted drug delivery. In this study, we tailored an aptamer-targeted liposomal drug delivery system for accumulation and delivery of antibiotics locally in S. aureus biofilm. In our search for a suitable targeting ligand, we identified six DNA aptamers that bound to S. aureus cells in biofilms, and we demonstrated that one of these aptamers could facilitate accumulation of liposomes around S. aureus cells inside the biofilm. Aptamer-targeted liposomes encapsulating a combination of vancomycin and rifampicin were able to eradicate S. aureus biofilm upon 24 h of treatment in vitro. Our results point to that aptamer-targeted drug delivery of antibiotics is a potential new strategy for treatment of S. aureus biofilm infections.
Original language | English |
---|---|
Article number | 814340 |
Journal | Frontiers in cellular and infection microbiology |
Volume | 12 |
Number of pages | 12 |
ISSN | 2235-2988 |
DOIs | |
Publication status | Published - 29 Apr 2022 |
Keywords
- Anti-Bacterial Agents/therapeutic use
- Biofilms
- Drug Delivery Systems
- Humans
- Liposomes
- Microbial Sensitivity Tests
- Staphylococcal Infections/drug therapy
- Staphylococcus aureus/genetics